Trilogy lifts guidance for full-year sales, earnings
Revenue in the 12 months ending March 31 is forecast to exceed $83 million.
Hot Topic
Hawke’s Bay
Trilogy International [NZX:TIL], the skincare and home fragrance company, raised its guidance for full-year sales and earnings, partly on the contribution from New Zealand cosmetics and fragrance distribution business, CS Company, acquired last August.
Revenue in the 12 months ending March 31 is forecast to exceed $83 million, up from the $75-79 million range given at the time of the first-half results and more than double the year-earlier period.
Earnings before interest and tax are expected to exceed $14 million, the top end of its previous guidance and profit before tax is forecast to top $13 million, compared to a previous guidance range of $10 million to $12 million.
Trilogy last year agreed to buy privately held CS Company, New Zealand's largest independent importer and distributor of fragrances, cosmetics and toiletries, for $37 million plus any earn-out payments. The purchase was debt funded. It added to assets including the Trilogy, Ecoya and Goodness brands.
Trilogy shares rose 2.2% to $3.30 and have soared 302% in the past 12 months.
The company plans to release its full-year results in May and give guidance for the 2017 year.
(BusinessDesk)
Jonathan Underhill
Thu, 10 Mar 2016
Thu, 10 Mar 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Related News
Related News
Trilogy lifts guidance for full-year sales, earnings
56361